Clinical stage T2 prostate cancer treated with radical prostatectomy has similar outcome across its substagesBiochemical recurrenceSurgical marginT1c prostate cancerRadical prostatectomyBackground: The objective of this study was to retrospectively review oncological outcome following radical prostatectomy (RP) ...
Materials and Methods Prostate specific antigen progression-free survival was assessed by the Kaplan-Meier method. Multivariate analyses were performed to determine which clinical and pathological variables independently correlated with progression. Comparisons among the various clinical substages (T1a to T2b...
Place in buffer (at 300C.) for five minutes. Wash slides again under running tap water for five minutes. Stain for five minutes with eosm. Wash eosin off with running water. Stain slides with freshly filtered hematoxylin for two to three minutes. Wash and dry in air. 展开 年份: 1967 ...
DelveInsight’s'Prostate Cancer Pipeline Insight 2024'report provides comprehensive global coverage of pipeline prostate cancer in various stages of clinical development, major pharmaceutical companies are working to advance the p...
In both stages A1 and A2 nondiploid peripheral zone cancers outnumbered nondiploid transition zone cancers. The relationship of tumor volume with ploidy is clearly different for peripheral zone and transition zone cancers. Eight peripheral zone cancers less than 2.0 cc were nondiploid but only 1 ...
Comparative Study of the Patients with Locally Advanced Stages I and II Cervical Cancer Treated by Radical Surgery with and without Preoperative Adjuvant C... Ninty-two patients with locally advanced stages IB, IIA, and IIB cervical cancers, who had completed 4 years of follow-up after treatment...
Since 1987, the annual number of newly diagnosed patients has gradually increased and we recognized stage migration, a tendency toward an annual decrease in the incidence of stages A and D and an increase in that of stage B. The stage distributions of SC group (223 cases) and NSC group (...
We compared tumor location and pathological parameters in the radical prostatectomy specimens of stages T1c versus T2 cases in a 3-year period. The percent of stage T1c disease represented a stable majority of patients undergoing treatment for clinically localized prostate cancer. From January 1, ...
[85]. Decreases in PARP Because the target of PARPis is mainly the PARP-1 protein, which is captured on SSBs and cannot be activated, decreases in PARP-1 levels will inevitably lead to PARPi resistance. Thus, PARPi sensitivity would be affected in tumor cells during different stages of ...
Rather dramatic (100% cancer-free) post-treatment prostate biopsy results were reported.9 It would seem, on the basis of this report, that combining adenovirus-mediated gene therapy with radiotherapy can impact all stages of localized prostate cancer, even the most aggressive forms. However, what...